TrianglePUBLICATIONS · 34388022
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2022 Jan 1
- First author
- Kersten MJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kersten MJ
- type
- Author
- name
- Amaador K
- type
- Author
- name
- Minnema MC
- type
- Author
- name
- Vos JMI
- type
- Author
- name
- Nasserinejad K
- type
- Author
- name
- Kap M
- type
- Author
- name
- Kastritis E
- type
- Author
- name
- Gavriatopoulou M
- type
- Author
- name
- Kraan W
- type
- Author
- name
- Chamuleau MED
- type
- Author
- name
- Deeren D
- type
- Author
- name
- Tick LW
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kersten MJ
- type
- Author
- name
- Amaador K
- type
- Author
- name
- Minnema MC
- type
- Author
- name
- Vos JMI
- type
- Author
- name
- Nasserinejad K
- type
- Author
- name
- Kap M
- type
- Author
- name
- Kastritis E
- type
- Author
- name
- Gavriatopoulou M
- type
- Author
- name
- Kraan W
- type
- Author
- name
- Chamuleau MED
- type
- Author
- name
- Deeren D
- type
- Author
- name
- Tick LW
- type
- Author
- bibliography ids
- nci-bib-e37607239e71187006408ef5
- book metadata
- content sha256
- b212cb822acfe5c18b26f07a033e940c066f58830fe19af65a717338e3ce9dea
- document type
- citation
- dois
- 10.1200/JCO.21.00105
- electronic publication date
- display
- 2021 Aug 13
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34388022
- immutable id
- pubmed:34388022@b212cb822acfe5c18b26f07a033e940c066f58830fe19af65a717338e3ce9dea
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 1
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 40-51
- volume
- 40
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34388022
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- b1088c608f78457f4e7a8f3d0c9e26d758ca91186800d6c6eb9514accab55e9a
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2022 Jan 1
- precision
- day
- year
- 2022
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study.
Preserved source evidence · Independent clinical review pending · Not medical advice